Concordant with the IWG-PM, ICC also excludes RUNX1 mutations from the SF3B1 entity supported by our data showing RUNX1 mutations as independent negative prognostic factors for OS and AML transformation. Here, SF3B1 is linked to acute myeloid leukemia.